Evidence map›Paper›PMID 41704565›Full record

ArticleNAR genomics and bioinformatics2026

DoBSeqWF: a framework for sensitive detection of individual genetic variation in pooled sequencing data.

Mads Cort Nielsen, Christian Munch Hagen, Ulrik Kristoffer Stoltze, Thomas van Overeem Hansen, Mette Nyegaard, Henrik Hjalgrim, Marie Bækvad-Hansen, Anna Byrjalsen, Kjeld Schmiegelow, Karin Wadt and 2 more

Abstract read
In one paragraph

Article in NAR genomics and bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Mads Cort NielsenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, KBH N, 2200, Denmark.ORCID https://orcid.org/0009-0009-4377-013X
Christian Munch HagenDepartment of Congenital Disorders, Statens Serum Institute, KBH S, 2300, Denmark.
Ulrik Kristoffer StoltzeDepartment of Clinical Genetics, Rigshospitalet, KBH Ø, 2100, Denmark.
Thomas van Overeem HansenDepartment of Clinical Genetics, Rigshospitalet, KBH Ø, 2100, Denmark.
Mette NyegaardDepartment of Congenital Disorders, Statens Serum Institute, KBH S, 2300, Denmark.
Henrik HjalgrimDepartment of Clinical Medicine, Copenhagen University, KBH N, 2200, Denmark.ORCID https://orcid.org/0000-0002-4436-6798
Marie Bækvad-HansenDepartment of Congenital Disorders, Statens Serum Institute, KBH S, 2300, Denmark.
Anna ByrjalsenDepartment of Clinical Genetics, Rigshospitalet, KBH Ø, 2100, Denmark.
Kjeld SchmiegelowDepartment of Pediatrics and Adolescent Medicine, Rigshospitalet, 2100, KBH Ø, Denmark.ORCID https://orcid.org/0000-0002-0829-4993
Karin WadtDepartment of Clinical Genetics, Rigshospitalet, KBH Ø, 2100, Denmark.ORCID https://orcid.org/0000-0003-2882-6798
Jonas Bybjerg-GrauholmDepartment of Congenital Disorders, Statens Serum Institute, KBH S, 2300, Denmark.
Simon RasmussenNovo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, KBH N, 2200, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Population screening for rare genetic diseases has the potential to increase early diagnosis and treatment, but the high cost of next-generation sequencing limits widespread implementation. Double-batched sequencing (DoBSeq) is a cost-effective method that uses two-dimensional overlapping pool sequencing to enable individual-level rare variant detection. However, the resulting high-depth, complex data require a specialized workflow for efficient, sensitive, and reproducible analysis. We developed DoBSeqWF (DoBSeq Workflow), a Nextflow-based pipeline that processes pooled sequencing data from alignment through variant calling, filtering, and final variant assignment. Using a childhood cancer cohort of 200 individuals with whole genome sequencing as a reference, we created training and validation datasets, benchmarked multiple variant callers, and implemented machine learning filters to improve rare variant detection while maintaining high sensitivity. DoBSeqWF demonstrates accurate and scalable rare variant detection within the evaluated experimental setting and provides a promising avenue for future cost-effective genetic screening programmes.

Indexed as

Genetic VariationHigh-Throughput Nucleotide SequencingSequence Analysis, DNASoftwareGenetic TestingHumansPooled TestingWhole Genome Sequencing

Identifiers

PMID41704565
PMCPMC12907731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.